- Home
- MUFG vs BMY Comparison
MUFG vs BMY Comparison
Compare MUFG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUFG
- BMY
- Stock Information
- Founded
- MUFG 1880
- BMY 1887
- Country
- MUFG Japan
- BMY United States
- Employees
- MUFG N/A
- BMY N/A
- Industry
- MUFG Commercial Banks
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- MUFG Finance
- BMY Health Care
- Exchange
- MUFG Nasdaq
- BMY Nasdaq
- Market Cap
- MUFG 143.3B
- BMY 120.5B
- IPO Year
- MUFG 2001
- BMY N/A
- Fundamental
- Price
- MUFG $11.87
- BMY $49.23
- Analyst Decision
- MUFG
- BMY Hold
- Analyst Count
- MUFG 0
- BMY 15
- Target Price
- MUFG N/A
- BMY $57.79
- AVG Volume (30 Days)
- MUFG 13.4M
- BMY 14.6M
- Earning Date
- MUFG 05-14-2025
- BMY 04-24-2025
- Dividend Yield
- MUFG 3.31%
- BMY 5.04%
- EPS Growth
- MUFG 37.26
- BMY N/A
- EPS
- MUFG 0.96
- BMY N/A
- Revenue
- MUFG $39,430,543,625.00
- BMY $48,300,000,000.00
- Revenue This Year
- MUFG $59.59
- BMY N/A
- Revenue Next Year
- MUFG $0.14
- BMY N/A
- P/E Ratio
- MUFG $12.05
- BMY N/A
- Revenue Growth
- MUFG 69.42
- BMY 7.32
- 52 Week Low
- MUFG $8.75
- BMY $39.35
- 52 Week High
- MUFG $15.03
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- MUFG 43.89
- BMY 25.85
- Support Level
- MUFG $11.50
- BMY $48.84
- Resistance Level
- MUFG $12.04
- BMY $51.60
- Average True Range (ATR)
- MUFG 0.46
- BMY 2.35
- MACD
- MUFG -0.07
- BMY -0.84
- Stochastic Oscillator
- MUFG 44.06
- BMY 3.20
About MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.0% share of all domestic loans as of March 2024. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.